Autologous osteoblastic cell therapy (Bone Therapeutics)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameAutologous osteoblastic cell therapy (Bone Therapeutics)

Drug Alias NameAutologous-preosteoblastic-cells-Bone-TherapeuticsAutologouspre- osteoblast-cell-therapy-Bone-TherapeuticsAutologous-pre-osteoblasticcell- therapy-Bone-TherapeuticsPREOB cellsAutologous-osteoblastic-cells-Bone-Therapeutics +[6]

ClassificationCell and gene therapy > Cell therapy > Donor > AutologousCell and gene therapy > Cell therapy > Somatic cell > Osteogenic cell therapy

Mechanisms of ActionCell replacementsOsteogenesis stimulants

TargetsNot applicable

Therapy Area/IndicationsLegg-Calve-Perthes DiseaseFemur Head Necrosis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgium

CombinationsNo

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesBone Therapeutics Sa

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBone Therapeutics Sa

Active IndicationsN/A

Inactive IndicationsLegg-Calve-Perthes DiseaseFemur Head Necrosis

Other Information

ATC CodeN/A